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doi:10.1016/j.jtcvs.2007.05.004bjective: Stem cell therapy in myocardial infarction is under intensive investiga-
ion; however, the mechanisms of recovery and the optimal transplantation tech-
ique remain controversial. The goal of this controlled and randomized study was
o test the hypothesis that locally injected bone marrow–derived mononuclear cells
an focus in on the damaged myocardium and improve cardiac function by means
f active participation in remodeling.
ethods: Myocardial infarction was introduced through occlusion of the circumflex
oronary artery for 90 minutes in 14 piglets (24.0  4.9 kg) that were randomized
o a cell-therapy group (n  7) and a control group (n  7). At reperfusion,
utologous purified prelabeled or unlabeled cells (108 cells/2 mL) or saline were
njected into the myocardium. Cardiac function was measured by using echocardi-
graphy preoperatively and postoperatively and at 3 weeks, when hearts were
ollected for histopathologic examination.
esults: The ejection fraction recovered in the cell-therapy group (P  .02) but
ailed to recover in the control group, and at 3 weeks, it remained at the lower level
ompared with that in the cell-therapy group (P  .067). The number of living cells
n the necrotic area was significantly greater in the cell-therapy group (P  .001).
abeled cells were detected in the infarcted area, and they showed signs of myocyte
ifferentiation. Furthermore, the proportional area of muscle actin-positive cells at
he granulation area was higher in the cell-therapy group (P  .035).
onclusions: Autologous bone marrow–derived mononuclear cells at the infarcted
rea localize in the myocardium. The exact mechanism of recovery remains to be
etermined, but our findings may give new information concerning the cellular
vents that occur during cell therapy–enhanced recovery.
nderstanding the functions of stem cells and learning to control them will
open new avenues for the treatment of many diseases. Knowledge about the
role of stem cells in myocardial recovery has increased substantially, but
any details of the mechanisms of cell differentiation and myocardium recovery are
till under investigation.
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CSPIt is known that stem cell transplantation to the damaged
yocardium improves recovery significantly compared
ith the normal injury-repairing processes occurring in the
yocardium. Histopathologic data from preclinical studies
ave confirmed the recovery of the infarcted area.1-3 Fur-
hermore, it is known that stem cells can differentiate to-
ard cardiomyocytes.4-7 It has been shown that the stem
ells release growth factors and signals in the myocardium
hat participate in tissue-repairing processes.8-10
Stem cell therapy in myocardial infarction is under in-
ensive investigation, although it has already been adopted
n clinical use. Most studies are based on the intracoronary
ransplantation method, and the intramyocardial method
as been used in only a few studies. These two transplan-
ation methods seem to be the most effective, safe, and
dministrable in clinical use. Perhaps the bone marrow–
erived mononuclear cells (BMMCs) are not the ideal type
f cells, but because of the lack of immunologic rejection
nd with easy access and purification, they are clinically
elevant, as recent studies have indicated. In addition, the
se of autologous BMMCs does not raise ethical issues in
linical application. The outcomes in clinical studies
uctuate from moderate to substantial recovery of the
yocardium.11-16
Positive preclinical results have shifted the focus of
esearch into clinical studies, despite the unknown func-
ional mechanisms of the stem cells. We find our experi-
ental porcine infarction model relevant in providing new
nformation for stem cell research.
We established a porcine acute myocardial infarction
odel, which mimics open coronary artery bypass grafting
urgery, to evaluate the efficacy of delivering bone marrow–
erived cells by means of direct injection into the damaged
yocardium. The hypothesis in our experimental design
as that BMMC transplantation immediately after infarc-
ion recovers the function of the heart after 3 weeks. Fur-
hermore, we wanted to clarify whether a direct injection
nto the infarcted area and into the border zone intensifies
oming of the stem cells and accelerates repair processes.
aterials and Methods
reoperative Management
wenty-six juvenile pigs (8–10 weeks of age) from a native stock
ere operated on in a sterile environment. The first 6 animals
Abbreviations and Acronyms
-SMA -smooth muscle actin
BMMC bone marrow–derived mononuclear cell
EF  ejection fraction
IQR  interquartile range
MSA muscle-specific actinnderwent feasibility experiments to optimize logistics and cell- e
66 The Journal of Thoracic and Cardiovascular Surgery ● Septeurifying techniques. Of the remaining 20 animals, 6 pigs died
uring coronary occlusion because of ventricular fibrillation.
hese animals were excluded from further analysis, and the deaths
ere not linked to cell or vehicle injection. Fourteen pigs were
andomized to the BMMC group (n  7) and a control group (n 
). The median weight of the pigs was 23.6 kg (interquartile range
IQR], 21.7–27.3 kg) in the cell-therapy group and 24.5 kg (IQR,
9.5–27.6 kg) in the control group. All animals received humane
are in accordance with the “Principles of laboratory animal care”
ormulated by the National Society for Medical Research and the
Guide for the care and use of laboratory animals” prepared by the
nstitute of Laboratory Animal Resources, National Research
ouncil (published by the National Academy Press, revised in
996). The study was approved by the Research Animal Care and
se Committee of the University of Oulu.
nesthesia
he animals were sedated with an intramuscular injection of
etamine hydrochloride (350 mg) and midazolam (45 mg). A
eripheral (venous) catheter was inserted into a vein of the right
ar for administration of drugs and to maintain fluid balance with
inger acetate. After an induction with fentanyl (25 g/kg admin-
stered intravenously) and pancuronium (0.2 mg/kg administered
ntravenously), the pigs were intubated, and the balanced anesthe-
ia was maintained with a continuous infusion of fentanyl (25
g · kg1 · h1), midazolam (0.25 mg · kg1 · h1), and pancuro-
ium (0.2 mg · kg1 · h1) and inhaled isoflurane (0.5%) in both
tudy groups throughout the whole experiment. The animals were
aintained on positive-pressure ventilation with 50% oxygen.
efuroxime (1.5 g administered intravenously) was administered
t anesthesia induction and before extubation.
solation of Mononuclear Cells
he animals were placed in a supine position, and 2  10 mL of
one marrow was aspirated beneath the tibial tuberosity into a
yringe containing 5000 IU of heparin. The bone marrow aspirates
ere delivered for isolation to the laboratory situated within the
ame facility as the operating room. The bone marrow aspirate
dilution 1:5 in phosphate-buffered saline, Sigma-Aldrich) was
assed through a density-gradient centrifugation (Ficoll-Paque
lus, Amersham Biosciences) to exclude erythrocytes and granu-
ocytes. Mononuclear cells were collected from the interphase and
ashed 3 times with phosphate-buffered saline. The cells were
hen suspended in a saline solution at a density of 50  106
ells/mL. Trypan blue dye was used to stain a fraction of isolated
ells to confirm the viability of more than 99% transplanted cells.
or the homing experiment, the isolated mononuclear cells were
abeled with Vybrant CM-DiI (Molecular Probes), according to the
anufacturer’s instructions.
emodynamic and Cardiac Function Monitoring
ransthoracic echocardiography was performed with the Acuson
eqouia 512 echocardiography system with a 3.5-MHz transducer
Siemens) preoperatively and at 30 minutes and 3 weeks after
nstituting reflow. The echocardiography was performed blinded to
he treatment group. The thicknesses of the ventricular walls (left
entricular posterior wall diameter, interventricular septum diam-
ter, left ventricular end-systolic diameter, and left ventricular
mber 2007
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Pnd-diastolic diameter) were measured from the M-mode view of
he left ventricle. The ejection fraction (EF) was calculated by
sing the Teichholz formula, and the left ventricular mass was
alculated by using the method described by Reichek and De-
ereux.17,18 Transmitral flow peaks E and A and their ratio were
easured from the 4-chamber view with the pulsed-wave Doppler
ample volume between mitral leaflet tips, and the isovolumetric
elaxation time was calculated from the aortic valve with contin-
ous-wave Doppler scanning. Cardiac output was measured by
sing the velocity-time integral of the pulsed-wave Doppler sam-
le from the left outflow tract, the diameter of the left outflow tract,
nd the heart rate.
An arterial catheter was positioned in the right femoral artery
or arterial pressure monitoring and blood sampling. A thermodi-
ution catheter (CritiCath, 7 F; Ohmeda GmbH & Co) was placed
hrough the right femoral vein to allow sampling of blood; mon-
toring of central venous pressure, pulmonary artery wedge pres-
ure, and pulmonary capillary wedge pressure; and recording of
lood temperature and cardiac output. During the occlusion of the
ircumflex coronary artery, the hemodynamic parameters were
easured every 15 minutes.
iochemical Analysis
lood gases, pH, electrolytes, serum ionized calcium levels, glu-
ose levels, hemoglobin levels (i-STAT analyzer, i-STAT Corp),
asic blood count, leukocyte differential count (Cell-Dyn analyzer,
bbott), and creatine kinase MB (Hydrasys LC-electrophoresis,
yrys-densitometry; Sebia) and troponin-I levels were measured
t baseline, at 90 minutes after the infarction, and at 30 minutes
nd 24 hours after initiation of reperfusion.
yocardial Infarction and BMMC Transplantation
he pericardium was opened through the left anterolateral thora-
otomy in the fourth intercostal space, and the heart was exposed.
he baseline parameters were recorded. The circumflex coronary
rtery was dissected just proximal to the left anterior descending
oronary artery. Myocardial infarction was instituted by occluding
he circumflex coronary artery with a removable silicone vascular
oop (Surg-I-Loop, Scanlan) for 90 minutes. The ligation was done
y the cardiac surgeon, who was unaware of the experimental
esign and the fate of the individual animals. At the end of the
schemic period, the silicone loop was removed, and 1 mL of
apaverine was administered on the vessel to avoid spasm; reper-
usion was confirmed visually. Immediately after the initiation of
eperfusion, autologous purified cells (108 cells/2 mL) or saline (2
L) were transplanted by means of intramyocardial injection into
he infarcted area. Solution was administered carefully with a
eedle (26-gauge) attached to a syringe to 10 different locations in
nd around the infarcted area. Prolene sutures (4-0; Ethicon, Inc)
ere used to mark the infarcted area. A single pleural tube was
sed for draining, and the thoracic cavity was closed. The animals
ere extubated 2 hours after reperfusion. On the following day, 24
ours postoperatively, the animals were sedated, and blood sam-
les were taken from the external jugular vein.
istopathologic Examination
t the 21st postoperative day, the pigs were sedated. Blood sam-
lings and measurements of hemodynamics and blood flow by s
The Journal of Thoraciceans of echocardiography were performed as previously de-
cribed. Each surviving animal was electively killed with an in-
ravenous injection of pentobarbital (60 mg/kg) and heparin (500
U/kg), and the hearts were removed for histopathologic analysis.
schemic and control tissue samples from the left ventricular wall
ere formalin fixed. The harvested tissues were paraffin embedded
nd sectioned at 5-m thickness for hematoxylin and eosin, Van
ieson, Von Kossa, and Masson trichrome staining. A single
athologist, who was unaware of the experimental design and the
ate of the individual animals, screened the sections of the heart
pecimens of each animal. The assessment of the injured area
ncluded the following: (1) granulation tissue, (2) the border zone
f the necrotic and fibrotic infarcted areas, and (3) the severely
nfarcted area (local necrosis). The quantity of living cells in the
ecrotic area was detected by using immunofluorescent Hoechst
taining (Developmental Studies Hybridoma Bank). Similarly, im-
unofluorescent Stro-1 staining (Developmental Studies Hybrid-
ma Bank) was used to detect stem cells in the necrotic area.
uantification of these 2 stained areas from the border zone and
ranulation tissue was totally prevented by the autofluorescence
aused by the degenerating cardiomyocytes. Quantification was
arried out by using a computer program (Scientific Image Anal-
sis; MCID-M4 3.0 Rev 1.1). Quantification of the immunostain-
ngs muscle-specific actin (MSA; DakoCytomation), myofibro-
last marker -smooth muscle actin (-SMA; DakoCytomation),
roliferation marker Ki-67 (NovoCastra), and the mesenchymal
ell marker vimentin (DakoCytomation) covered the whole ne-
rotic area and surrounding border zone of the necrosis of the
amples. Quantification of the granulation tissue was limited so
hat at least a double-sized area compared with the necrotic area
igure 1. Bone marrow– derived mononuclear cell (BMMC) in-
ection at the infarction site enables ejection fraction recovery.
he ejection fraction decreased after infarction critically (>15%)
n both groups (!P  .03). After the 3-week recovery period, the
jection fraction increased significantly in the BMMC group
*P  .02) but remained at the same decreased level in the
ontrol group. Data points represent actual median values 
tandard deviation.
and Cardiovascular Surgery ● Volume 134, Number 3 567
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CSPas quantified. That limitation was needed because of the huge
ize of the granulation tissue compared with the other areas.
ikewise, variations of the infarct of each animal set its own
imitations. The proportional area of cell coverage was counted
rom MSA, -SMA, Ki-67, and vimentin stainings. The propor-
ional area of the cell coverage was counted by using Van Gieson
taining also to assess the amount of collagen in the granulation
issue. Stains were prepared with the immunoperoxidase method
EnVision).
For the cell-tracking analysis, 2 additional pigs received a
ransplantation of fluorescent DiI dye–labeled cells. After 3 weeks
f follow-up, these animals were electively killed. Tissues from
he liver, lung, spleen, and hilar lymph nodes and infarcted and
ormal tissue of the heart were sampled. Samples were paraffin
mbedded, sectioned, and prepared for analysis. DiI-labeled cells
ere detected from each sample by using a fluorescent micro-
cope. Because these pigs did not conform to the original protocol,
he results obtained were analyzed separately. Expression of
-SMA positivity in DiI–labeled cells was quantified from the
ranulation tissue area. For the analysis, granulation tissue was
ivided into 3 areas: (1) organized granulation tissue, (2) border
one, and (3) unorganized granulation tissue. Similarly, the per-
entage of -SMA–labeled cells from total -SMA cells was
alculated. Also, the percentage of -SMA–labeled cells at-
ached to the vessel structures was determined.
tatistical Analysis
tatistical analysis was performed with the SPSS statistical pro-
ram (SPSS version 14.0; SPSS, Inc, Chicago, Ill). Continuous and
rdinal variables are expressed as the median with the IQR (25th–
5th percentiles). Complete independence was assumed across
nimals (by random statement). The Mann–Whitney U test was
sed to assess the distribution of variables between study groups.
ignificance levels are reported for comparisons with the 2-tailed
ABLE 1. Group statistics: Echocardiography
Protocol N
VEDD (mm) BMMC group 7 2
Control group 7 3
VESD (mm) BMMC group 7 1
Control group 7 1
max (cm/s) BMMC group 7 6
Control group 7 6
max (cm/s) BMMC group 7 4
Control group 7 4
/A BMMC group 7 1
Control group 7 1
VRT (ms) BMMC group 7
Control group 7
eart rate (beats/min) BMMC group 7 9
Control group 7 10
F (%) BMMC group 7 6
Control group 7 7
chocardiographic data represent medians and interquartile ranges (25th
entricular end-systolic diameter; Emax, maximal transmitral E-wave; Amax
VRT, isovolumetric relaxation time; EF, ejection fraction. *P  .02.est. F
68 The Journal of Thoracic and Cardiovascular Surgery ● Septeesults
he groups did not differ significantly in any preoperative
arameters. There were no significant differences between
he groups preoperatively and postoperatively in infarction
arkers. In both groups a significant release of heart en-
ymes was observed postoperatively compared with base-
ine values, indicating that a critical-sized infarction had
ccurred. This was also confirmed by means of visual
bservation of the infarcted area during the operation. The
ean weight of the animals increased in both groups in 3
eeks. The increase in the median weight was 11.5 kg
IQR, 10.8–14.8 kg) in the BMMC group and 8.4 kg (IQR,
.4–9.2 kg) in the control group; the weight increase was
igher in the BMMC group (P  .05).
emodynamic Analysis
he 90-minute occlusion of the circumflex coronary artery
esulted in a significant reduction in EF compared with the
aseline value (P  .03), and there was no difference
etween the groups. In the BMMC group EF decreased
rom 65.7% (IQR, 61.5%–78.5%) at baseline to 56.8%
IQR, 49.8%–61.7%); in the control group the decrease was
rom 74.3% (IQR, 71.9%–77.4%) to 62.7% (IQR, 51.3%–
5.9%). After the 3-week recovery period, EF increased
ignificantly in the BMMC group (56.8% [IQR, 49.8%–
1.7%] vs 74.1% [IQR, 72.3%–78.4%], P  .02)
ut remained at the same decreased level in the control
roup (62.7% [IQR, 51.3%–65.9%] vs 62.4% [IQR,
5.9%–64.8%]. The increase in EF after the recovery pe-
iod was higher after the BMMC injection (P  .067,
seline Postoperative 3 wk postoperative
8.7–31.6) 30.2 (29.9–32.6) 37.6 (37.4–39.3)
8.8–38.8) 30.1 (28.9–35.3) 36.5 (34.5–43.4)
4.3–21.5) 22.1 (21.2–23.9) 21.6 (19.5–22.4)
4.4–22.4) 22.0 (19.9–22.9) 22.8 (22.0–30.9)
7.9–67.0) 46.8 (37.5–53.3) 61.6 (54.5–93.3)
7.3–77.9) 58.0 (50.0–74.9) 67.4 (58.3–90.4)
2.3–53.9) 39.1 (35.8–43.3) 52.5 (33.5–57.1)
2.5–46.0) 46.6 (42.5–53.6) 47.6 (39.6–86.7)
.23–1.65) 1.19 (0.83–1.38) 1.47 (1.29–1.65)
.44–1.94) 1.18 (1.12–1.51) 1.14 (0.94–1.49)
.0–8.7) 7.5 (5.3–7.6) 5.7 (5.4–6.4)
.2–8.0) 7.5 (5.5–8.4) 8.5 (6.7–9.3)
9.0–108.0) 115.0 (100.0–135.0) 115.0 (103.0–118.5)
03.0–113.0) 121.0 (105.0–129.0) 120.0 (99.5–131.0)
1.5–78.5) 56.8 (49.8–61.7) 74.1 (72.3–78.4)*
1.9–77.4) 62.7 (52.0–67.2) 61.2 (55.9–64.7)
percentile). LVEDD, Left ventricular end-diastolic diameter; LVESD, left
mal transmitral A-wave; E/A, transmitral flow peaks E and A and their ratio;Ba
9.3 (2
0.1 (2
9.1 (1
8.5 (1
3.3 (5
9.9 (5
0.8 (3
1.6 (3
.47 (1
.58 (1
8.0 (8
8.0 (7
5.0 (8
9.0 (1
5.7 (6
4.3 (7
–75th
, maxiigure 1).
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PThe left ventricular end-diastolic diameter increased sim-
larly in both groups during the 3-week recovery period. The
hanges in the left ventricular mass and wall dimensions
ere similar in both groups. In diastolic parameters the
ransmitral flow peaks E and A and their ratio decreased
fter infarction in both groups and failed to recover in 3
eeks in both groups. The isovolumetric relaxation time did
ot change during the procedure (Table 1).
istopathologic Analysis
ll animals in the study groups had a large infarction, which
as, as expected, located in the posterior wall of the left
entricle. Four of the 7 animals in both study groups had
ecrotic material in the center of the infarction area, and for
hose 4  4 animals, histologic analysis could be
erformed.
For the 2 animals that were not included in the study
roups, DiI-labeled cells were transplanted in a similar
anner, and these cells were detected in the injection/
amaged area but not from the healthy area of the myocar-
ium. Labeled cells were also found in the perihilar lymph
igure 2. Injected DiI-labeled cells remain at the infarct site. Trans-
lanted DiI-labeled (white arrows) cells were detected by using a
uorescent microscope (magnification 20) from the infarcted area
A) and from some of the perihilar lymph nodes (B). A sample from
ndamaged heart muscle was negative (C), as were samples from
he liver (D), spleen (E), and lungs (F). Bars  100 m.odes but not in any other organs sampled, such as the liver, l
The Journal of Thoracicpleen, or lungs (Figure 2). The labeled cells that were
bserved in the infarcted myocardium showed positive ex-
ression of the proliferation marker Ki-67, the mesenchy-
al cell marker vimentin, -SMA, and MSA, which was
etected by immunostaining for these antigens. The DiI-
abeled cells were found both in the necrotic area and the
order zone; however, most of the labeled cells could be
ound in the area surrounding the severe infarction site (ie,
n the active remodeling site; Figure 3). -SMA DiI-
abeled cells quantified from the organized granulation tis-
ue area showed a median percentage of 94.4% (IQR,
2.3%–100%) of -SMA positivity in DiI-labeled cells.
imilarly, in the border zone of organized and unorganized
ranulation tissue, the median percentage of -SMA DiI-
igure 3. Injected DiI-labeled cells differentiate at the injection
ite. DiI-positive cells in the granulation tissue area at the in-
arcted myocardium showed positive expression of -smooth
uscle actin (-SMA; A and B), Ki-67 (C and D; magnification
20), vimentin (E and F; magnification 40), and muscle-specific
ctin (MSA; G and H; magnification 60). Bars  20 m.abeled cells was 92.1% (IQR, 87.5%–100%). In the unor-
and Cardiovascular Surgery ● Volume 134, Number 3 569
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5
CSPanized granulation tissue the median percentage of
-SMA DiI–labeled cells was 23.8% (IQR, 20.0%–
5.0%). The percentage of -SMA DiI-labeled cells from
otal -SMA cells in the organized granulation tissue was
5.0% (IQR, 22.6%–31.6%). Likewise, in the border zone
f the granulation tissues, the percentage was 27.5% (IQR,
5.4%–28.1%), and in the unorganized granulation tissue
he percentage was 4.1% (IQR, 2.5%–5.1%). The median
ercentage of -SMA DiI-labeled cells attached to the
essel structures in the organized granulation tissue was
4.3% (IQR, 11.1%–23.1%). In the border zone of the
ranulation tissues, the median percentage was 60.3% (IQR,
3.3%–87.5%), and in the unorganized granulation tissue
he median percentage was 9.5% (IQR, 8.7%–13.3%).
The quantity of cells recruited in the necrotic area was
alculated by using Hoechst staining, which showed a sig-
ificantly larger quantity of living cells in the BMMC group
P  .001). Moreover, Stro-1–positive cells could be de-
ected similarly (P  .001). In addition, Stro-1–positive
ells accumulated in the vessel walls of the necrotic area
Figure 4). Notable is that Stro-1–positive cells were de-
ected in larger quantities particularly in the border zone and
n moderate quantities in the granulation tissue. However,
uantification of these 2 stainings from the border zone and
ranulation tissue was totally prevented by the autofluores-
ence caused by the degenerating cardiomyocytes. For the
istopathologic analysis, control biopsy specimens from the
ealthy areas of each heart were taken and stained with c
70 The Journal of Thoracic and Cardiovascular Surgery ● Septeoechst and Stro-1. Stro-1–positive cells were not found in
hose tissue samples.
A proportional area of cell coverage was counted from
he immunohistologic samples by using vimentin, Ki-67,
SA, and -SMA antibodies. The number of vimentin-
ositive mesenchymal cells was significantly higher in the
order zone (P  .001) and in the necrotic area (P  .013)
n the BMMC group. The proportional area of cell coverage
or muscle actin staining was higher in the granulation
issue area in the BMMC group (P  .035, Figure 5).
mooth muscle actin staining showed no difference be-
ween the groups. Proliferation marker Ki-67 staining
howed no differences between the groups in any sector of
he defined infarction. Van Gieson staining was used to
ssess the collagen in the granulation tissue, and no differ-
nce was observed between the groups.
iscussion
he experimental model used in this study is based on a
ritical-sized myocardial infarction, and it mimics clinically
situation in which coronary occlusion results in a severe
nd permanent cardiac injury. A considerable decrease in
F and a significant release of heart enzymes were observed
n every animal after the 90-minute occlusion of the cir-
umflex coronary artery, confirming the severity of myo-
ardial infarction. The injection of BMMCs into the myo-
Figure 4. Injection of bone marrow–
derived mononuclear cells (BMMC)
enhances cell survival and recruitment
at the infarction site parenchyma.
Larger quantities of living cells in the
necrotic area were observed with a
fluorescent microscope (magnification
20) in the BMMC group by using
Hoechst staining (A and B) compared
with the control group (E and F). In cell
counting a significant difference be-
tween the groups could readily be ob-
served (I; ***P < .001). Similarly, a
larger number of Stro-1–positive cells
was detected in the BMMC group (C,
D, and J; P < .001) compared with the
control group (G and H). The highest
density of Stro-1–positive cells was
detected at the vessel walls in the
BMMC group (D) in contrast to the con-
trol group (H). Bars in A, C, E, and G 
100 m; bars in B, D, F, and H 20 m.ardium ameliorated EF decrease in 3 weeks.
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CS
PThe principal finding of this study was that the number of
esenchymal cells in the border zone and in the necrotic
rea was higher after injection of BMMCs. This observation
as based on a counted proportional area of the cell cov-
rage. Moreover, the quantity of viable cells (Hoechst stain-
ng) in the necrotic area of the infarct was significantly
arger in the BMMC group. In addition, the accumulation of
he Stro-1–positive cells could be found in the vessel walls
n the necrotic area. These findings indicate that the border
one and the necrotic area of the infarct attract mesenchy-
al cells. A larger amount of mesenchymal cells at theamaged tissue after injury can accelerate or modify the M
The Journal of Thoracicatural injury-repairing processes. It is notable that despite
he larger number of living cells in the infarcted tissue and
round the necrotic area, the cell proliferation itself was
imilar in both groups. Therefore proliferation as such
eems to be more or less a standard process evoked by
nitial repair processes and cannot be accelerated by extend-
ng the number of BMMCs in the area. Thus, it might be
lausible that the number of the cells, per se, is not a
efining feature of proliferation; rather, the cells that pro-
iferate might be different.
An interesting finding in our study was that expression of
Figure 5. Injection of bone marrow–
derived mononuclear cells (BMMC)
promotes postinfarction remodeling.
Analysis of the immunohistologic
staining with a light microscope re-
vealed differences between the con-
trol and BMMC groups (images with
10 magnification are shown). En-
hanced vimentin staining (A and C),
indicating a larger quantity of mesen-
chymal cells in the necrotic area (E;
P < .01) and in the border zone (F; P <
.001), could be seen in the BMMC
group. For the muscle actin staining (B
and D), the proportional area of cell
coverage was greater in the granula-
tion tissue area (G) in the BMMC group
(P  .035). Bars  50 m.SA in the labeled cells in the histologic analysis was
and Cardiovascular Surgery ● Volume 134, Number 3 571
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CSPetected, which opens the field for the following question:
an these labeled stem cells turn into myocytes? That kind
f finding is presented in several other reports.5,6 However,
he magnitude of the cells expressing MSA is insufficient to
xplain the recovery of the EF. Thus, as has been sug-
ested,9 other mechanisms induced or mediated by the
tem cells would be responsible for the healing effect.
his idea is also supported by our histopathologic find-
ngs showing that the infarcted area in the BMMC group
eems to have more muscle actin and mesenchymal cells
ompared with the infarcted area in the control group. All
hese data in combination support the possibility that
ellular therapy has a locally significant effect on the
nduction of cell repair.
At 3 weeks after infarction, the healing processes had
learly modified the infarcted myocardium. Local necrosis,
he granulation tissue area, and the border zone between the
ecrotic and granulation tissue areas could be easily iden-
ified in the histopathologic analysis. The model used here
epresents the initial steps of recovery, however, and this
hould be kept in mind when these data are interpreted: the
bserved differences between the BMMC group and the
ontrol group represent only one time point in a long heal-
ng process. Nevertheless, the BMMCs transplanted by
eans of intramyocardial injection into the infarcted area
eem to remain in the heart muscle for the observed 3-week
eriod, and these cells decrease scar formation or modulate
car development. The DiI-labeled and living cells could be
ound in all named infarct-conjugated areas, but it was
bvious that the signs of expression of MSA were mainly
oncentrated in the granulation tissue area. The labeled
MMCs not only survived at the injection site for 3 weeks
ut also proliferated, and a fraction of these cells showed
ositive expression of skeletal muscle actin. The viable
nfarcted area appeared to be supportive enough for those
ells to start the proliferation and other injury-repairing
rocesses. The same processes occurred also in the control
roup, although to a lower degree. The fact that live labeled
ells were detected in the border of the necrotic area and in
he necrotic area reveals that the repairing processes initi-
ted by the stem cells cover the area from the outer fringes
o the core of the injured area. This was clearly not the case
n the control group, which might explain the observed
ifference between the groups: the center of the damaged
rea is physically reachable only after a longer period with-
ut a direct introduction of cells into the area. It is notice-
ble, however, that the labeled cells in the severely infarcted
rea hardly showed any signs of expression of MSA. The
uantity of the living cells (Hoechst staining) and Stro-1–
ositive cells in the necrotic area was significantly higher in
he BMMC group, and labeled cells without expression of
ny specific antibody could be observed in the same area.
hese data suggest that the unorganized infarcted area is
72 The Journal of Thoracic and Cardiovascular Surgery ● Septender such repairing processes that expression of MSA of the
abeled cells is neither possible nor induced at this site and also
hat the viable cells introduced in the damaged tissue might act
s signaling centers for the repair process. It is obvious that at
east parts of the necrotic areas were beyond repair, and there-
ore the cellular changes were more pronounced in the viable,
ufficiently perfused areas of myocardial tissue.
It has been shown that the smooth muscle actin in the
ranulation tissue indicates the presence of myofibroblasts
nd that these cells contribute to the ongoing scar tissue
ollagen turnover and subsequent fibrous tissue forma-
ion.19,20 Although the smooth muscle actin staining showed
o difference between the groups, in the BMMC group there
ere perceivably lower amounts of myofibroblasts in the
ranulation tissue and more in the border zone of the
ecrotic area. More than 90% of DiI-labeled cells in the
rganized granulation tissue were -SMA, whereas in the
norganized granulation tissue only, their proportion was
3%. Hence it appears that the injected cells could have
ifferent contributions depending on their location in rela-
ion to the damage. It appears that the injected cells were
ore concretely at work in the organized granulation tissue,
nd in the unorganized milieu they would exist as signaling
enters. As has been described, in the native situation the
yofibroblasts proliferate and cover the necrotic area
ooner or later.21 Hence the injected cells can have an
ccelerating or facilitating effect on that process. However,
t still remains under discussion whether the injected cells
an indeed turn the myofibroblasts sooner toward their
ontractile form.
Our data confirm that transplantation of BMMCs im-
roves the function of the heart and enhances myocardial
ecovery after severe experimental infarction. The injected
ells showed signs of participating in the repair process in
ll damage-linked areas. The detailed molecular mecha-
isms that regulate these processes require more profound
xperimental research, which is still needed to provide
ptimal therapy for clinical use.
Because of the model used, the clinical relevance of our
tudy is limited. The healing effect in juvenile pigs is
robably more pronounced than it would be in adult pigs.
he recovery of the function is based on M-mode echocar-
iography, and it might overestimate the real magnitude of
he recovery. It is remarkable, however, that the healing
ffect was also seen in the histologic analysis and in con-
ordance with the mechanical improvement.
We thank Timo Kaakinen, Pasi Ohtonen, Päivi Laurila, Seija
eljänperä, Minna Savilampi, Mari Karsikas, Suvi Tiinanen, and
oz Grave for their valuable technical assistance.
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